Abstract | OBJECTIVES: To determine whether Zuidex using a non-cystoscopy mid-urethral injection technique produces as good a result (i.e. was not inferior) as Contigen injected endoscopically at the bladder neck in the treatment of urinary stress incontinence secondary to intrinsic sphincter deficiency in adult women. METHODS: A prospective 2:1 randomized trial of mid-urethral injections of Zuidex-Implacer vs proximal urethral cystoscopic injections of Contigen was performed in 344 women with intrinsic sphincter deficiency at 23 North American sites, and followed up for >1 year from last treatment. RESULTS: Outcomes at 12 months from last treatment failed to demonstrate that mid-urethral injected Zuidex was equivalent to cystoscopically injected Contigen in primary and secondary outcome variables. The primary outcome, the proportion of women who achieved a 50% reduction in urinary leakage on provocation testing, was achieved in 84% of Contigen-treated women vs 65% of Zuidex-treated women. CONCLUSIONS: Confounding multiple variables inherent in the study design make a detailed analysis of study outcomes difficult.
|
Authors | Deborah Lightner, Eric Rovner, Jacques Corcos, Christopher Payne, Linda Brubaker, Harold Drutz, Gary Steinhoff, Zuidex Study Group |
Journal | Urology
(Urology)
Vol. 74
Issue 4
Pg. 771-5
(Oct 2009)
ISSN: 1527-9995 [Electronic] United States |
PMID | 19660800
(Publication Type: Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biocompatible Materials
- Dextrans
- dextranomer-hyaluronic acid copolymer
- glutaraldehyde-cross-linked collagen
- Hyaluronic Acid
- Collagen
|
Topics |
- Biocompatible Materials
(administration & dosage)
- Collagen
(administration & dosage)
- Cystoscopy
- Dextrans
(administration & dosage)
- Female
- Humans
- Hyaluronic Acid
(administration & dosage)
- Injections
- Middle Aged
- Prospective Studies
- Urethra
- Urinary Incontinence, Stress
(therapy)
|